2 days ago · Eikon is planning to become the second biotech to go public in 2026 in another sign the public markets are looking attractive to drug developers.

All the information you need to install and to download Refinitiv Eikon. Direct link to test if your system can run Refinitiv Eikon.

12 hours ago · Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for more on the upcoming EIKN offering.

4 days ago · Eikon, a high-profile startup led by Merck vets, seeks an IPO Run by Roger Perlmutter and backed by more than $1 billion in private funding, Eikon will use the IPO …

5 days ago · Eikon Therapeutics Inc. filed for an initial public offering to help fund its advanced pipeline of cancer drugs.

Eikon Therapeutics filed for an initial public offering. The late-stage clinical biopharmaceutical company didn't disclose in its Friday filing the price or amount of shares it would offer. It ...

Eikon Therapeutics is a late-stage clinical biopharmaceutical firm developing innovative medicines for serious unmet medical needs, with an initial focus on oncology.

5 days ago · Eikon Therapeutics filed for a Nasdaq IPO after raising $1.1 billion for cancer drugs, led by ex-Amgen and Merck exec Roger Perlmutter.

Feb 26, 2025 · Since its founding in 2019, Eikon Therapeutics has privately raised in excess of $1.1 billion to support its mission of developing new medicines to address grievous illnesses. …

2 days ago · Hair loss–focused Veradermics and cancer biotech Eikon follow the lead of Aktis Oncology, which last week announced a $318 million IPO target.